surely the optimal end goal would be publicly funded drug research labs, with budget allocations comparable to what the pharmaceutical firms spend. surprising t

surely the optimal end goal would be publicly funded drug research labs, with budget allocations comparable to what the pharmaceutical firms spend. surprising that the article never even touched upon that.